BamSEC and AlphaSense Join Forces
Learn More

AdaptHealth Corp. – Material Contracts

NASDAQ: AHCO    
Share price (6/12/26): $10.16    
Market cap (6/12/26): $1.382 billion

Material Contracts Filter

EX-10.1
from 10-Q 35 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 1 page AdaptHealth Corp. Non-Employee Director Fee Deferral Policy Effective as of May 30, 2025
12/34/56
EX-10.2
from 10-Q 2 pages February 23, 2023 Re: Updated Employment Letter
12/34/56
EX-10.1
from 10-Q 11 pages 1.position. You Are Offered the Position of Senior Vice President, Accounting Reporting to the Chief Financial Officer With a Start Date of on or Around October 1, 2022. as an Employee of Adapthealth, Corp., You Will Be Expected to Perform Your Duties and Responsibilities in an Ethical, Professional, and Diligent Manner. You Will Also Be Expected to Comply With All Applicable Laws and the Company’s Policies and Procedures, Which May Be Amended From Time to Time. You Will Serve as a Full-Time Employee of the Company. 2. Compensation. A)base Wages: You Will Be Compensated at an Annual Salary of $300,000. This Will Be Paid in Accordance With the Company's Applicable Payroll Practices and Will Be Subject to Applicable Taxes and Withholdings. B)performances Bonuses: At the Sole Discretion of the Company, You Will Be Eligible to Participate in the Following AdaptHealth’s Management Incentive Bonus Programs
12/34/56
EX-10.1
from 8-K 1 page Amendment to Transition, Separation, and Release Agreement
12/34/56
EX-10.1
from 8-K 34 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 19 pages AdaptHealth Corp Indemnification Agreement
12/34/56
EX-10.2
from 8-K 12 pages Transition, Separation and Release Agreement
12/34/56
EX-10.1
from 8-K 34 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 12 pages Transition, Separation and Release Agreement
12/34/56
EX-10.1
from 8-K 25 pages AdaptHealth Corp. Second Amended and Restated 2019 Stock Incentive Plan
12/34/56
EX-10.3
from 10-Q 1 page Re: Revised Offer of Employment Dear Shaw: It Is My Pleasure to Extend a Revised Offer of Employment With AdaptHealth Corp. Any Terms Not Addressed Below Will Remain the Same as Those Set Out in Your Previous Offer of Employment. the Key Terms of This Employment Offer Are as Follows: 1. Compensation. A) Base Wages: Effective January 1, 2024, You Will Be Compensated an Annual Salary of $500,000. This Will Be Paid in Accordance With the Company's Applicable Payroll Practices and Will Be Subject to Applicable Taxes and Withholdings
12/34/56
EX-10.2
from 10-Q 2 pages Material contract
12/34/56
EX-10.1
from 10-Q 1 page April 28, 2023 Re: Revised Offer of Employment Dear Shaw: It Is My Pleasure to Provide Documentation for Your Revised Employment Agreement Terms With AdaptHealth Corp. Any Terms Not Addressed Below Will Remain the Same as Those Set Out in Your Previous Offer of Employment Effective 02/26/2020: The Key Terms Are as Follows: 1. Compensation. A.BASE Compensation. Effective October 2, 2021, You Will Be Compensated at an Annual Salary of $400,000 Less Any Applicable Statutory and Regulatory Deductions. the Base Salary Will Be Paid in Accordance With the Company’s Regular Payroll Practices
12/34/56
EX-10.3
from 8-K 2 pages April 15, 2024 Re: Amendment to Employment Agreement 1. Section 7(c) of the Employment Agreement Is Hereby Deleted in Its Entirety and Replaced With the Following
12/34/56
EX-10.2
from 8-K ~1 page April 15, 2024 Electronic Delivery Richard Barasch Re: Fifth Extension of Transition Date · From and After May 1, 2024, the Term “Transition Date” as Used in the Letter Agreement Shall Refer to May 19, 2024 or Such Earlier Date as Determined by the Board; · 100% of the Fourth Extension Rsus Will Vest as of April 30, 2024;
12/34/56
EX-10.1
from 8-K 27 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 1 page March 3, 2024 Electronic Delivery Richard Barasch Re: Fourth Extension of Transition Date · From and After March 1, 2024, the Term “Transition Date” as Used in the Letter Agreement Shall Refer to April 30, 2024 or Such Earlier Date as Determined by the Board; · 100% of the Third Extension Rsus Vested as of February 29, 2024; · Following the Expiration of the Interim Period (As the Same May Be Extended by Mutual Agreement Between You and the Company), There Will Be No Transition Period and You Will Cease to Serve as an Executive Officer of the Company as of the Close of Business on Transition Date; And
12/34/56
EX-10.31
from 10-K 48 pages United States District Court Eastern District of Pennsylvania
12/34/56
EX-10.1
from 8-K 1 page December 21, 2023 Electronic Delivery Richard Barasch Re: Third Extension of Transition Date · From and After the Date Hereof, the Term “Transition Date” as Used in the Letter Agreement Shall Refer to February 29, 2024 or Such Earlier Date as Determined by the Board; · 100% of the Second Extension Rsus Will Vest on December 31, 2023 Subject to Your Continuous Employment Through Such Date; · Following the Expiration of the Interim Period (As the Same May Be Extended by Mutual Agreement Between You and the Company), There Will Be No Transition Period and You Will Cease to Serve as an Executive Officer of the Company as of the Close of Business on Transition Date; And
12/34/56